newest glp-1 drugs 6 Things to Know About the New Weight Loss Pill GLP-1 Drug Savings: A Complete

They should not be used during pregnancy, and caution is needed in patients with history of pancreatitis, gallbladder disease, or diabetic retinopathy

PMCID: PMC3349454

Although we have long known that A1C targets are not effective, this guideline recommends focusing completely on cardiovascular and renal risk as long as A1C is less than 9%

1 Introduction Inflammatory bowel disease (IBD), comprising Crohns disease (CD) and ulcerative colitis (UC), is a multifactorial, chronic, immune-mediated inflammatory disorder that affects the gastrointestinal system

doi: 10.4314/tjpr.v12i5.15 222 Hernndez-MijaresABaulsCPerisJEMonzNJoverABellodLet al

A similar impact on biomarkers of liver damage has also been demonstrated for lixisenatide [75], dulaglutide [78,79], liraglutide [73,76,77] and semaglutide [61,80]